CORONA Main Coronavirus thread

Shadow

Shadow

Swift, Silent,...Sleepy
All the events reported in China may be 100% true. However, after all the BS that came out of China with people falling dead suddenly on the sidewalks and such during the beginning of covid, I have a hard time believing reports from there. Maybe they are telegraphing what they want to do elsewhere or they are just fueling the fear fire.

Shadow
 
jward

jward

passin' thru
Dr Aseem Malhotra
@DrAseemMalhotra

Cardiologist,campaigner,best selling author.On a mission to save lives with REAL evidence based medicine & REAL food.Tweets personal opinion,NOT medical advice
DoctorLondondoctoraseem.com/biography/

Joined January 2012
2,893 Following
360.9K Followers

Dr Aseem Malhotra
@DrAseemMalhotra

I’ve just been contacted by a very eminent Dr from a London teaching hospital. He’s double vaxed, helped with the roll out but is now extremely concerned about serious harms of the mRNA jabs not just from his own observations but from the hard data too. He’s ready to help

7:46 AM · Dec 28, 2022

1672242784496.png
 
Valann

Valann

Contributing Member
Shadow said:
All the events reported in China may be 100% true. However, after all the BS that came out of China with people falling dead suddenly on the sidewalks and such during the beginning of covid, I have a hard time believing reports from there. Maybe they are telegraphing what they want to do elsewhere or they are just fueling the fear fire.

Shadow
Click to expand...
Exactly my first thoughts on that as well. I was sucked in the first go around when they were showing people dropping dead in the streets and so on. I have that skeptical look going on now!
 
psychgirl

psychgirl

Has No Life - Lives on TB
Shadow said:
All the events reported in China may be 100% true. However, after all the BS that came out of China with people falling dead suddenly on the sidewalks and such during the beginning of covid, I have a hard time believing reports from there. Maybe they are telegraphing what they want to do elsewhere or they are just fueling the fear fire.

Shadow
Click to expand...
And unfortunately this is the reason why this new “disease” will spread! All because of the rampant lying and distrust.
We still need to just wait and see what happens:(
 
psychgirl

psychgirl

Has No Life - Lives on TB
Chinese citizens leaving China, having arrived in Italy, are infected!

I think this horse is out of the barn now. :(



https://twitter.com/i/web/status/1608153225537921026
View: https://twitter.com/danishdibiasky/status/1608153225537921026

https://twitter.com/i/web/status/1608157532664770560
View: https://twitter.com/alexmeshkin/status/1608157532664770560?cxt=HHwWgMDR1a2wqdEsAAAA


And also
https://twitter.com/i/web/status/1608111188604506112
View: https://twitter.com/alexmeshkin/status/1608111188604506112?cxt=HHwWgMDSweOmlNEsAAAA
 
psychgirl

psychgirl

Has No Life - Lives on TB
Zoner said:
Turnbull continues to declare a new and more lethal variant has emerged. But why isn’t this being confirmed yet? Certainly Alexander, Eads, McCollough and others should be saying something.

https://twitter.com/i/web/status/1608231955514163200
View: https://twitter.com/enemyinastate/status/1608231955514163200?s=46&t=e44KJ5vsVXRFTBVcrDahSw
Click to expand...
I’ve asked that same question!

The whole thing smells very very fishy if you ask me.

It’s like the whole world is starting to scream but no one’s listening!
 
Zoner

Zoner

Veteran Member
psychgirl said:
I’ve asked that same question!

The whole thing smells very very fishy if you ask me.

It’s like the whole world is starting to scream but no one’s listening!
Click to expand...
Maybe they haven’t done the sequencing I don’t know?
Maybe everybody’s off between Christmas and New Year’s?
Maybe they’re just testing positive for Covid and they are simply treating it without identifying what variant it is?
But they have experts in the UK and Ireland. They should at least tell us it’s the same variant.
I’ll keep an eye on Twitter
 
Heliobas Disciple

Heliobas Disciple

TB Fanatic
psychgirl said:
Chinese citizens leaving China, having arrived in Italy, are infected!

I think this horse is out of the barn now. :(



https://twitter.com/i/web/status/1608153225537921026
View: https://twitter.com/danishdibiasky/status/1608153225537921026

https://twitter.com/i/web/status/1608157532664770560
View: https://twitter.com/alexmeshkin/status/1608157532664770560?cxt=HHwWgMDR1a2wqdEsAAAA


And also
https://twitter.com/i/web/status/1608111188604506112
View: https://twitter.com/alexmeshkin/status/1608111188604506112?cxt=HHwWgMDSweOmlNEsAAAA
Click to expand...

www.livemint.com

Milan reports 50% of passengers on China flights have Covid

Italy is now sequencing those tests to see if there are new variants coming from China
www.livemint.com www.livemint.com
(fair use applies)


Milan reports 50% of passengers on China flights have Covid
Updated: 28 Dec 2022, 09:57 PM IST

SYNOPSIS
Italy is now sequencing those tests to see if there are new variants coming from China

Italian health authorities will begin testing all arrivals from China for Covid after almost half of the passengers on two flights to Milan were found to have the virus.

The country is now sequencing those tests to see if there are new variants coming from China, the Health Ministry said in a statement. If a new strain is found, officials may impose stricter curbs on travel from China.

China has seen outbreaks of the virus since the government there abandoned its strict zero-Covid policies. Uncertainty over the scale of the spread has prompted many countries to consider new restrictions on entry from the country.

In Germany, health authorities are “closely watching" the situation in China, according to Health Ministry spokesman Sebastian Guelde.

“We have no indication that a more dangerous mutation has developed in China that would give rise to a declaration of a virus variant area, which would result in corresponding travel restrictions," he added.

Milan’s regional health chief said at a press conference Wednesday that airport authorities tested passengers who arrived on two flights, one from Beijing and one from Shanghai.

While the high rate of passengers with the virus has put authorities on alert, one factor in Italy’s favor is its high vaccination rate. More than 80% of people are fully inoculated, according to the Word Health Organization, and many have also received booster shots. It’s a similar story across much of Western Europe.
 
Heliobas Disciple

Heliobas Disciple

TB Fanatic
Shadow said:
All the events reported in China may be 100% true. However, after all the BS that came out of China with people falling dead suddenly on the sidewalks and such during the beginning of covid, I have a hard time believing reports from there. Maybe they are telegraphing what they want to do elsewhere or they are just fueling the fear fire.

Shadow
Click to expand...

Official CCP reports coming from there are almost non-existent. They are keeping very quiet on what's going on and trying to contain the info. I don't trust the CCP either and don't recommend trusting them for a second on anything covid related. I think the word of mouth reports being snuck out (with video) may be more reliable, but of course, could also be planted by the CCP. No way of knowing. If you don't believe there is a threat from what's happening in China, then take it to prayer. No one has definitive answers, we are all doing our best to stay ahead of any major problem and preparing ourselves not only physically, but spiritually and mentally (just like we did back when this thread got started in Jan 2020; this thread was ahead of the curve for a lot of people who had a 2 month head start to get ready before the MSM really got into warning people).

Valann said:
Exactly my first thoughts on that as well. I was sucked in the first go around when they were showing people dropping dead in the streets and so on. I have that skeptical look going on now!
Click to expand...

Again, no one here is trying to convince anyone of anything. We have all gone through the last 3 years, we've all had our experiences and our own takeaways. For a very long time, we who have been on this thread all along have been following a virologist named Dr. Geert Vanden Bossche and he has been shouting from the rooftops that the vaccine is going to breed a more virulent (ie deadly) and transmissable variant, that will evade vaccine protection, probably by the end of 2022. That is a lot of the our bias, and it is a bias, but we have been following him and waiting to see if he was right. No one wants him to be right but he is probably the smartest virologist of the entire bunch and he was adamant. So when we read about what's going on in China, and Japan, and the UK/Ireland, we are not ignoring it. Now had we never heard of Geert or his theories, I bet most of us would be skeptical too... to be totally frank... but we've been listening to him for more than 2 years, so that's framing how we view this news. Again, take it to prayer and if you have time seek out some of his videos on Rumble. (or search the thread, I think they've all been posted here)


psychgirl said:
And unfortunately this is the reason why this new “disease” will spread! All because of the rampant lying and distrust.
We still need to just wait and see what happens:(
Click to expand...

yep. very true.

HD
 
Heliobas Disciple

Heliobas Disciple

TB Fanatic
Zoner said:
Maybe they haven’t done the sequencing I don’t know?
Maybe everybody’s off between Christmas and New Year’s?
Maybe they’re just testing positive for Covid and they are simply treating it without identifying what variant it is?
But they have experts in the UK and Ireland. They should at least tell us it’s the same variant.
I’ll keep an eye on Twitter
Click to expand...

Thank you.

I also think (layperson opinion) that the tests are picking up a lot more false negatives than false positives, and have all through the pandemic. Especially now. They are going to have to rely on something other than the tests to diagnose. That is if they really want to know what's going on and get a handle on it. Maybe they don't. :shr:

HD
 
Heliobas Disciple

Heliobas Disciple

TB Fanatic
More idiocy of promoting travel. GREED. It's not one of the deadly sins for no reason... :(


news.yahoo.com

Asia's tourist hotspots prepare for boom as China relaxes COVID rules

Asian countries are bracing for an influx of Chinese tourists as COVID restrictions are dismantled, and while some are wary, operators in others are preparing packages such as hotpot buffets to cash in on the expected spike in travel. Chinese tourists will no longer need to quarantine on return...
news.yahoo.com news.yahoo.com
(fair use applies)


Asia's tourist hotspots prepare for boom as China relaxes COVID rules
Chayut Setboonsarng, Xinghui Kok and Stella Qiu
Thu, December 29, 2022, 12:49 AM EST

BANGKOK/SINGAPORE/SYDNEY (Reuters) - Asian countries are bracing for an influx of Chinese tourists as COVID restrictions are dismantled, and while some are wary, operators in others are preparing packages such as hotpot buffets to cash in on the expected spike in travel.

Chinese tourists will no longer need to quarantine on return home starting Jan. 8, the government announced this week, a move that spurred a surge in bookings from what was the world's largest outbound travel market in 2019.

The once $255 billion a year in global spending by Chinese tourists ground to a virtual halt during the pandemic, leaving a gaping hole in the Asian market, where countries from Thailand to Japan had depended on China as the largest source of foreign visitors.

International flights to and from China are at just 8% of pre-pandemic levels, VariFlight data shows, but carriers are looking to ramp up capacity as authorities ease COVID-driven limits on the number of flights.

"There is little doubt mainland Chinese are the spark plug for Thailand's tourism recovery," said Bill Barnett, managing director of hospitality consultancy C9 Hotelworks. "It's not a question of if it will happen, it's now just a matter of how many and how fast."

Malaysia Airlines and Vietnamese budget carrier VietJet Aviation said they hope to restore China flights to pre-pandemic levels by June 2023, while others such as Singapore Airlines and Australia's Qantas Airways declined to provide detailed targets as the situation evolves.

Chinese airlines are likely to make significant increases to capacity from the end of March, coinciding with the start of the summer scheduling season, Morningstar analyst Cheng Weng told clients in a note.

REBOUND "WITH A VENGEANCE"

The prospect of cash-rich Chinese flocking to shopping streets across the world boosted luxury stocks this week, as China accounts for 21% of the world's 350 billion euro ($371.91 billion) luxury goods market.

As the Lunar New Year holiday - typically a peak travel period for Chinese tourists - starts on Jan. 21, some businesses are already gearing up.

Sofitel Sentosa in Singapore is creating Lunar New Year packages aimed at Chinese visitors, including a hotpot buffet and romantic packages for couples, said Cavaliere Giovanni Viterale, general manager of that hotel and the upcoming Raffles Sentosa, as the company bets that a travel rebound will come "with a vengeance".

In Japan, tour bus firm Hato Bus says next month it will try out Chinese-language tours it had halted during the pandemic, with the aim of a full resumption by the spring, a spokesperson said.

Japan, however, is being cautious about Chinese tourism due to the rapid spread of the virus in China. It is requiring a negative COVID-19 test on arrival from Chinese visitors, and those who test positive must quarantine for seven days under new border measures taking effect on Dec. 30.

The United States said it would impose mandatory COVID tests on travellers from China, joining India, Italy and Taiwan in taking new measures, while the Philippines is considering a testing requirement.

Australia, Germany, Thailand and others, however, said they would not impose additional rules on Chinese travel for now, with France taking to social media platform Sina Weibo to emphasise it welcomed Chinese friends "with open arms".

In Vietnam, where tourist visas for Chinese are not yet being issued, Saigon Halong Hotel in Halong Bay expects it will receive Chinese arrivals from the second quarter of next year.

Any hopes of a massive rebound in Chinese travel to Australia during the Lunar New Year holiday are probably misplaced, James Shen, general manager of Melbourne-based tour agency Odyssey Travel said, citing sky-high airfares.

"There are still very few flights and they would be booking very last minute," he said. "I suspect any meaningful rebound will have to wait until the travel boom in June or July next year."
 
Heliobas Disciple

Heliobas Disciple

TB Fanatic
justthenews.com

'Pfizer and Moderna better get this clarified': Study finds worse antibodies after mRNA boosters

Increased proportion of post-booster IgG4 antibodies, known for helping humans adapt to allergies, "might result in longer viral persistence in case of infection," German researchers conclude. Italian study found IgG4 concentration correlated with COVID-related mortality.
justthenews.com justthenews.com
(fair use applies)



'Pfizer and Moderna better get this clarified': Study finds worse antibodies after mRNA boosters
Increased proportion of post-booster IgG4 antibodies, known for helping humans adapt to allergies, "might result in longer viral persistence in case of infection," German researchers conclude. Italian study found IgG4 concentration correlated with COVID-related mortality.
By Greg Piper
Updated: December 28, 2022 - 11:12pm

A new peer-reviewed study is raising concerns that a third dose of Pfizer and Moderna vaccines may actually worsen immune response against COVID-19, creating waves in both mainstream and heterodox COVID circles.

Published in Science Immunology last week, the study by German researchers found that mRNA boosting induced a high level of so-called IgG4 antibodies, a subclass known for prompting a mild immune response, in two cohorts of several dozen healthcare workers.

The "shift" to this IgG subclass was "not seen with adenovirus vector vaccines" in the study, Scripps Research Translational Institute Director Eric Topol, who was not involved in the research, tweeted while cautioning that "clinical significance is not known."

"Pfizer and Moderna better get this clarified," California gastroenterologist Farid Jalali, who once pressured the FDA to fast-track COVID vaccines for infants, wrote in response to Topol before marking his account private.

The research is just the latest to prompt scrutiny of federal vaccine recommendations and ongoing professional and educational mandates, particularly for college students, a demographic with low COVID risks but elevated risks of post-jab heart inflammation.

The CDC still recommends everyone 6 months and older receive a full series and booster of the original Wuhan strain vaccine, topped off with the new bivalent Wuhan-Omicron booster, regardless of COVID risk level or likelihood of adverse reactions.

The agency's own research has found superior protection against reinfection from natural immunity when compared to mRNA vaccines as well as low bivalent effectiveness against symptomatic infection, to the point where two doses protect better than three.

IgG4 antibodies, known for their noninflammatory properties, constituted just 0.04% of all IgG subclasses shortly after the second mRNA dose, the German study says. The fourth subclass started ramping up several months after the full series and reached a high of 19.27% "late after the third vaccination."

"Importantly, this class switch was associated with a reduced capacity of the spike-specific antibodies to mediate antibody-dependent cellular phagocytosis [ingesting and eliminating pathogens] and complement deposition," the study's introduction says.

Serum samples taken after the booster and "normalized to the amount of anti-spike antibodies yielded significant[ly] lower phagocytic scores than sera from the same donors after two immunizations," the study found.

The increased IgG4 "might result in longer viral persistence in case of infection," according to the researchers, most of whom are associated with the University of Erlangen-Nuremberg. The findings "may have consequences for the choice and timing" of mRNA vaccine regimens, including subsequent boosters.

Co-author Kilian Schober wrote in a tweet thread that the 1-in-5 proportion of IgG4 after boosting jumped to 40-80% of antibodies after subsequent breakthrough infections, which is "very unusual."

While the researchers "saw improved antibody avidity [accumulated binding] and cross-neutralization after 3rd vs. 2nd vaccination," he said, the "fragment crystallizable" antibody functions on cell receptors "are indeed deteriorated (!)."

But Schober also cautioned against the view "among some anti-vax circles," prompted by the paper's preprint release this summer, that mRNA vaccines are inducing "tolerance" to infection rather than fighting it.

The study didn't answer whether "the class switch [is] irrelevant in terms of consequences on subsequent infections," he said. It is "conceivable" that the noninflammatory IgG4 response prevents "immunological over-activation while virus is still being neutralized [blocked from entering] via high-avidity antibody variable regions."

The IgG4 subclass is associated with increased COVID-related mortality, according to a letter by Italian researchers published in Elvesier's European Journal of Internal Medicine a year ago.

"Because anti-spike IgG4 have shown poor in vitro neutralizing capacity compared to IgG1, IgG2, and IgG3 antibodies, a first possibility is that hosts with prominent IgG4 immune responses might be more permissive to SARS-CoV-2 infection," according to those San Raffaele Scientific Institute researchers.

The German paper cites their Italian colleagues as well as an early-pandemic Brazilian study that found "early onset and high levels" of IgG4 antibodies correlated with a "more severe" COVID progression from infection, "which might indicate a less effective antibody response." But it is "also possible that a more severe infection leads to an IgG4 response and not vice versa."

Just the News asked the FDA and CDC for their evaluation of the study and how it might affect their promotion of "up to date" vaccination and future booster authorizations. The FDA said it might not be able to give an answer until January, while the CDC didn't respond. Pfizer and Moderna didn't respond to queries either.

Philippines doctor Michael David Sy, who wrote a book critical of the country's COVID response, said the German research had prompted him to "recommend against mRNA boosters unless more studies debunk this one or more comprehensive studies surface."

The IgG4 switch is "great if it's a benign or inert substance, like pollen, but NOT with virulent entities like COVID-19," he wrote. "Successive mRNA boosts no longer seem to be a salient answer in our fight against COVID-19."

Former New York Times drug industry reporter Alex Berenson also invoked allergies as a common prompt for IgG4 response.

Unlike IgG1-3, the fourth subclass "does little to help other immune system cells attack viral or bacterial invaders directly," Berenson wrote in a review of prior IgG4 research. Beekeepers, for example, have high IgG4 concentrations from repeat exposure to bee venom.

While the fourth subclass can still neutralize the virus and IgG antibodies aren't the only defense, he said, the German research "offers more evidence that mRNA booster campaigns need to be immediately restricted." Scientists also must study the post-vaccination sickness level of those with high IgG4 levels compared to those with low levels, Berenson said.
 
Heliobas Disciple

Heliobas Disciple

TB Fanatic
scitechdaily.com

Off-Patent Liver Disease Drug Could Stop COVID-19 and Protect Against Future Variants

Unique experiments involved ‘mini-organs’, animal research, donated human organs, volunteers, and patients. Cambridge scientists have shown that a widely-used drug to treat liver disease can prevent SARS-CoV-2 infection or reduce COVID-19 severity The drug has minimal side effects, is cheap,
scitechdaily.com
(fair use applies)


Off-Patent Liver Disease Drug Could Stop COVID-19 and Protect Against Future Variants​

By University of Cambridge
December 28, 2022

Researchers at Cambridge University have found that a previously existing, off-patent medication may be effective in preventing COVID-19 and potentially guarding against future variants of the virus. The discovery was made through a combination of experiments using mini-organs, donor organs, animal studies, and patient data.

Unique experiments involved ‘mini-organs’, animal research, donated human organs, volunteers, and patients.
  • Cambridge scientists have shown that a widely-used drug to treat liver disease can prevent SARS-CoV-2 infection or reduce COVID-19 severity
  • The drug has minimal side effects, is cheap, and should protect against future variants of SARS-CoV-2
  • Their unique study involved ‘mini-organs’, animal research, donated human organs, volunteers, and patients

View: https://www.youtube.com/watch?v=3haZDrAcWY8&feature=emb_imp_woyt
1 min 50 sec

Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future variants of the virus – in research involving a unique mix of ‘mini-organs’, donor organs, animal studies, and patients.

The research, published recently in the journal Nature, showed that an existing drug used to treat a type of liver disease is able to ‘lock’ the doorway by which SARS-CoV-2 enters our cells, a receptor on the cell surface known as ACE2.
Because this drug targets the host cells and not the virus, it should protect against future new variants of the virus as well as other coronaviruses that might emerge.

If confirmed in larger clinical trials, this could provide a vital drug for protecting those individuals for whom vaccines are ineffective or inaccessible as well as individuals at increased risk of infection.

Dr. Fotios Sampaziotis, from the Wellcome-MRC Cambridge Stem Cell Institute at the University of Cambridge and Addenbrooke’s Hospital, led the research in collaboration with Professor Ludovic Vallier from the Berlin Institute of Health at Charité.

Dr. Sampaziotis said: “Vaccines protect us by boosting our immune system so that it can recognize the virus and clear it, or at least weaken it. But vaccines don’t work for everyone – for example patients with a weak immune system – and not everyone has access to them. Also, the virus can mutate into new vaccine-resistant variants.

“We’re interested in finding alternative ways to protect us from SARS-CoV-2 infection that are not dependent on the immune system and could complement vaccination. We’ve discovered a way to close the door to the virus, preventing it from getting into our cells in the first place and protecting us from infection.”

From mini-organs and animals…​

Dr. Sampaziotis had previously been working with organoids – ‘mini-bile ducts’ – to study diseases of the bile ducts. Organoids are clusters of cells that can grow and proliferate in culture, taking on a 3D structure that has the same functions as the part of the organ being studied.

Using these, the researchers found – rather serendipitously – that a molecule known as FXR, which is present in large amounts in these bile duct organoids, directly regulates the viral ‘doorway’ ACE2, effectively opening and closing it. They went on to show that ursodeoxycholic acid (UDCA), an off-patent drug used to treat a form of liver disease known as primary biliary cholangitis, ‘turns down’ FXR and closes the ACE2 doorway.

In this new study, his team showed that they could use the same approach to close the ACE2 doorway in ‘mini-lungs’ and ‘mini-guts’ – representing the two main targets of SARS-CoV-2 – and prevent viral infection.

The next step was to show that the drug could prevent infection not only in lab-grown cells but also in living organisms. For this, they teamed up with Professor Andrew Owen from the University of Liverpool to show that the drug prevented infection in hamsters exposed to the virus, which are used as the ‘gold-standard’ model for pre-clinical testing of drugs against SARS-CoV-2. Importantly, the hamsters treated with UDCA were protected from the delta variant of the virus, which was new at the time and was partially resistant to existing vaccines.

Professor Owen said: “Although we will need properly-controlled randomized trials to confirm these findings, the data provide compelling evidence that UDCA could work as a drug to protect against COVID-19 and complement vaccination programs, particularly in vulnerable population groups. As it targets the ACE2 receptor directly, we hope it may be more resilient to changes resulting from the evolution of the SARS-CoV-2 spike, which result in the rapid emergence of new variants.”

… to human organs…​


Next, the researchers worked with Professor Andrew Fisher from Newcastle University and Professor Chris Watson from Addenbrooke’s hospital to see if their findings in hamsters held true in human lungs exposed to the virus.

The team took a pair of donated lungs not suitable for transplantation, keeping them breathing outside the body with a ventilator and using a pump to circulate blood-like fluid through them to keep the organs functioning while they could be studied. One lung was given the drug, but both were exposed to SARS-CoV-2. Sure enough, the lung that received the drug did not become infected, while the other lung did.

Professor Fisher said: “This is one of the first studies to test the effect of a drug in a whole human organ while it’s being perfused. This could prove important for organ transplantation – given the risks of passing on COVID-19 through transplanted organs, it could open up the possibility of treating organs with drugs to clear the virus before transplantation.”

… to people​


Moving next to human volunteers, the Cambridge team collaborated with Professor Ansgar Lohse from the University Medical Centre Hamburg-Eppendorf in Germany.

Professor Lohse explained: “We recruited eight healthy volunteers to receive the drug. When we swabbed the noses of these volunteers, we found lower levels of ACE2, suggesting that the virus would have fewer opportunities to break into and infect their nasal cells – the main gateway for the virus.”

While it wasn’t possible to run a full-scale clinical trial, the researchers did the next best thing: looking at data on COVID-19 outcomes from two independent cohorts of patients, comparing those individuals who were already taking UDCA for their liver conditions against patients not receiving the drug. They found that patients receiving UDCA were less likely to develop severe COVID-19 and be hospitalized.

A safe, affordable variant-proof drug​


First author and PhD candidate Teresa Brevini from the University of Cambridge said: “This unique study gave us the opportunity to do really translational science, using a laboratory finding to directly address a clinical need.

“Using almost every approach at our fingertips we showed that an existing drug shuts the door on the virus and can protect us from COVID-19. Importantly, because this drug works on our cells, it is not affected by mutations in the virus and should be effective even as new variants emerge.”

Dr. Sampaziotis said the drug could be an affordable and effective way of protecting those for whom the COVID-19 vaccine is ineffective or inaccessible. “We have used UDCA in clinic for many years, so we know it’s safe and very well tolerated, which makes administering it to individuals with high COVID-19 risk straightforward.

“This tablet costs little, can be produced in large quantities fast and easily stored or shipped, which makes it easy to rapidly deploy during outbreaks – especially against vaccine-resistant variants, when it might be the only line of protection while waiting for new vaccines to be developed. We are optimistic that this drug could become an important weapon in our fight against COVID-19.”

View: https://www.youtube.com/watch?v=ygRtWh5a4NE&feature=emb_imp_woyt
1 min 34 sec

Reference: “FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2” by Teresa Brevini, Mailis Maes, Gwilym J. Webb, Binu V. John, Claudia D. Fuchs, Gustav Buescher, Lu Wang, Chelsea Griffiths, Marnie L. Brown, William E. Scott III, Pehuén Pereyra-Gerber, William T. H. Gelson, Stephanie Brown, Scott Dillon, Daniele Muraro, Jo Sharp, Megan Neary, Helen Box, Lee Tatham, James Stewart, Paul Curley, Henry Pertinez, Sally Forrest, Petra Mlcochova, Sagar S. Varankar, Mahnaz Darvish-Damavandi, Victoria L. Mulcahy, Rhoda E. Kuc, Thomas L. Williams, James A. Heslop, Davide Rossetti, Olivia C. Tysoe, Vasileios Galanakis, Marta Vila-Gonzalez, Thomas W. M. Crozier, Johannes Bargehr, Sanjay Sinha, Sara S. Upponi, Corrina Fear, Lisa Swift, Kourosh Saeb-Parsy, Susan E. Davies, Axel Wester, Hannes Hagström, Espen Melum, Darran Clements, Peter Humphreys, Jo Herriott, Edyta Kijak, Helen Cox, Chloe Bramwell, Anthony Valentijn, Christopher J. R. Illingworth, UK-PBC research consortium, Bassam Dahman, Dustin R. Bastaich, Raphaella D. Ferreira, Thomas Marjot, Eleanor Barnes, Andrew M. Moon, Alfred S. Barritt IV, Ravindra K. Gupta, Stephen Baker, Anthony P. Davenport, Gareth Corbett, Vassilis G. Gorgoulis, Simon J. A. Buczacki, Joo-Hyeon Lee, Nicholas J. Matheson, Michael Trauner, Andrew J. Fisher, Paul Gibbs, Andrew J. Butler, Christopher J. E. Watson, George F. Mells, Gordon Dougan, Andrew Owen, Ansgar W. Lohse, Ludovic Vallier and Fotios Sampaziotis, 5 December 2022, Nature.
DOI: 10.1038/s41586-022-05594-0

The research was largely funded by UK Research & Innovation, the European Association for the Study of the Liver, the NIHR Cambridge Biomedical Research Centre and the Evelyn Trust.
 
Heliobas Disciple

Heliobas Disciple

TB Fanatic
auxman said:
Tested positive yesterday for a third time. Temp 99.9, sinuses dripping like an Amazon rain forest. Overall, like a bad cold... pureblood.
Click to expand...

I'm sorry to hear this, but glad it's only a bad cold for you. But don't over do anything, take it easy and let your body heal up and rest up. Keep up your Vitamins D, C and Zinc, with Quercitin too.

Geert has said everyone will catch this, vaxxed and unvaxxed. His theory is that the unvaxxed will use their immune systems to overcome it and it will be like a bad cold for them, so your experience seems to fit his theory. (if that's any comfort for you). But help your immune system out with the antivirals and vitamins!

Adding my prayers for you and any family living in your home who may also be exposed.

HD
 
Zoner

Zoner

Veteran Member
I’ve been praying this prayer tonight I will continue my intercessions for those here and abroad.

Psalm 91
1 ¶ He who dwells in the secret place of the Most High shall abide under the shadow of the Almighty.
2 I will say of the LORD, “He is my refuge and my fortress; My God, in Him I will trust.”
3 Surely He shall deliver you from the snare of the fowler and from the perilous pestilence.
4 He shall cover you with His feathers,
And under His wings you shall take refuge;
His truth shall be your shield and buckler.
5 You shall not be afraid of the terror by night, nor of the arrow that flies by day,
6 Nor of the pestilence that walks in darkness, nor of the destruction that lays waste at noonday.
7 A thousand may fall at your side,
And ten thousand at your right hand;
But it shall not come near you.
8 Only with your eyes shall you look,
And see the reward of the wicked.
9 Because you have made the LORD, who is my refuge, even the Most High, your dwelling place,
10 No evil shall befall you, nor shall any plague come near your dwelling;
11 For He shall give His angels charge over you, to keep you in all your ways.
12 In their hands they shall bear you up,
Lest you dash your foot against a stone.
13 You shall tread upon the lion and the cobra, the young lion and the serpent you shall trample underfoot.
14 “Because he has set his love upon Me, therefore I will deliver him;
I will set him on high, because he has known My name.
15 He shall call upon Me, and I will answer him; I will be with him in trouble;
I will deliver him and honor him.
16 With long life I will satisfy him,
And show him My salvation.”
 
You must log in or register to reply here.
Top